Literature DB >> 10742309

A redox-based mechanism for nitric oxide-induced inhibition of DNA synthesis in human vascular smooth muscle cells.

R E Bundy1, N Marczin, A H Chester, M Yacoub.   

Abstract

1. The current study explored potential redox mechanisms of nitric oxide (NO)-induced inhibition of DNA synthesis in cultured human and rat aortic smooth muscle cells. 2. Exposure to S-nitrosothiols, DETA-NONOate and NO itself inhibited ongoing DNA synthesis and S phase progression in a concentration-dependent manner, as measured by thymidine incorporation and flow cytometry. Inhibition by NO donors occurred by release of NO, as detected by chemiluminescence and judged by the effects of NO scavengers, haemoglobin and cPTIO. 3. Co-incubation with redox compounds, N-acetyl-L-cysteine, glutathione and L-ascorbic acid prevented NO inhibition of DNA synthesis. These observations suggest that redox agents may alternatively attenuate NO bioactivity extracellularly, interfere with intracellular actions of NO on the DNA synthesis machinery or restore DNA synthesis after established inhibition by NO. 4. Recovery of DNA synthesis after inhibition by NO was similar with and without redox agents suggesting that augmented restoration of DNA synthesis is an unlikely mechanism to explain redox regulation. 5. Study of extracellula interactions revealed that all redox agents potentiated S-nitrosothiol decomposition and NO release. 6. Examination of intracellular NO bioactivity showed that as opposed to attenuation of NO inhibition of DNA synthesis by redox agents, there was no inhibition (potentiation in the presence of ascorbic acid) of soluble guanylate cyclase (sGC) activation judged by cyclic GMP accumulation in rat cells. 7. These data provide evidence that NO-induced inhibition of ongoing DNA synthesis is sensitive to redox environment. Redox processes might protect the DNA synthesis machinery from inhibition by NO, in the setting of augmented liberation of biologically active NO from NO donors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10742309      PMCID: PMC1571988          DOI: 10.1038/sj.bjp.0703240

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Differential regulation of DNA synthesis by nitric oxide and hydroxyurea in vascular smooth muscle cells.

Authors:  R Bundy; N Marczin; A H Chester; M Yacoub
Journal:  Am J Physiol       Date:  1999-11

2.  Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells.

Authors:  J S Pollock; U Förstermann; J A Mitchell; T D Warner; H H Schmidt; M Nakane; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor.

Authors:  J Stamler; M E Mendelsohn; P Amarante; D Smick; N Andon; P F Davies; J P Cooke; J Loscalzo
Journal:  Circ Res       Date:  1989-09       Impact factor: 17.367

4.  DNA damage and mutation in human cells exposed to nitric oxide in vitro.

Authors:  T Nguyen; D Brunson; C L Crespi; B W Penman; J S Wishnok; S R Tannenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

5.  Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry.

Authors:  P S Wong; J Hyun; J M Fukuto; F N Shirota; E G DeMaster; D W Shoeman; H T Nagasawa
Journal:  Biochemistry       Date:  1998-04-21       Impact factor: 3.162

6.  Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.

Authors:  J P Cooke; A H Singer; P Tsao; P Zera; R A Rowan; M E Billingham
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Inactivation of ribonucleotide reductase by nitric oxide.

Authors:  M Lepoivre; F Fieschi; J Coves; L Thelander; M Fontecave
Journal:  Biochem Biophys Res Commun       Date:  1991-08-30       Impact factor: 3.575

8.  Mechanism of assembly of the tyrosyl radical-dinuclear iron cluster cofactor of ribonucleotide reductase.

Authors:  J M Bollinger; D E Edmondson; B H Huynh; J Filley; J R Norton; J Stubbe
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

9.  Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols.

Authors:  L J Ignarro; C A Gruetter
Journal:  Biochim Biophys Acta       Date:  1980-08-13

10.  Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide.

Authors:  N S Kwon; D J Stuehr; C F Nathan
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  4 in total

1.  Antioxidants modulate the antiproliferative effects of nitric oxide on vascular smooth muscle cells and adventitial fibroblasts by regulating oxidative stress.

Authors:  Elaine K Gregory; Ashley K Vavra; Edward S Moreira; George E Havelka; Qun Jiang; Vanessa R Lee; Robert Van Lith; Guillermo A Ameer; Melina R Kibbe
Journal:  Am J Surg       Date:  2011-09-23       Impact factor: 2.565

2.  Thioredoxin restores nitric oxide-induced inhibition of protein kinase C activity in lung endothelial cells.

Authors:  Katriina Kahlos; Jianliang Zhang; Edward R Block; Jawaharlal M Patel
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

3.  Nitrosative stress treatment of E. coli targets distinct set of thiol-containing proteins.

Authors:  Nicolas Brandes; Andrea Rinck; Lars Ingo Leichert; Ursula Jakob
Journal:  Mol Microbiol       Date:  2007-10-05       Impact factor: 3.501

Review 4.  Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview.

Authors:  Monica Marra; Ignazio M Sordelli; Angela Lombardi; Monica Lamberti; Luciano Tarantino; Aldo Giudice; Paola Stiuso; Alberto Abbruzzese; Rossella Sperlongano; Marina Accardo; Massimo Agresti; Michele Caraglia; Pasquale Sperlongano
Journal:  J Transl Med       Date:  2011-10-10       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.